Akriderm GK ointment d / nar. approx. tube 15g # 1
Dosage:
0.05% x 30g
0.05% + 0.1% + 1% x 15g
0.05% + 0.1% + 1% x 30g
Release form:
Cream
Ointment
Category
Psoriasis
Scope of the drug
Dermatology
Release form
Ointment
Manufacturer country
Russia
Package quantity, pcs
one
Structure
1 g contains 0.64 mg betamethasone dipropionate
excipients: nipagin
hard paraffin
petrolatum
propylene glycol
medical vaseline oil
emulsifying cetostearyl alcohol type A or emulsifying wax type Lanette SX"
disodium salt of ethylenediaminetetraacetic acid (Trilon B)
sodium sulfite 7-aqueous
purified water
pharmachologic effect
Akriderm GK is a combined drug that has anti-inflammatory, antiallergic, antibacterial and antifungal (fungicidal) effects. Gentamicin is a broad-spectrum antibiotic from the aminoglycoside group, it has a bactericidal effect. Highly sensitive gram-negative microorganisms - Proteus spp. (indole positive and indole negative), Escherichia coli, Klebsiella spp., Salmonella spp., Shigella spp., Campylobacter spp., Staphylococcus spp. (methicillin-resistant). Sensitive: Enterococcus faecalis, Serratia spp., Pseudomonas spp., Acinetobacter spp., Citrobacter spp. Resistant: Neisseria meningitidis, Treponema pallidum, anaerobic microbes: Streptococcus spp. (except Streptococcus pneumoniae), Enterococcus faecalis Providencia rettgeri. Betamethasone - glucocorticosteroid,has a local anti-inflammatory, anti-edema, anti-allergic effect.
Clotrimazole is an antifungal agent from the group of imidazole derivatives for topical use.
It acts by disrupting the synthesis of ergosterol, which is an integral part of the cell membrane of fungi.
Possesses a wide spectrum of action.
Active against pathogenic dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum, Microsporum canis), yeast and mold fungi (Candida spp., Torulopsis glabrata, Rhodotorula spp., Pityrosporum orbicare).
Indications
Simple and allergic dermatitis (especially complicated by secondary infection), diffuse neurodermatitis (including atopic dermatitis), limited neurodermatitis (including simple chronic lichen), eczema, dermatomycosis (dermatophytosis, candidiasis, versicolor versicolor), especially when localized in the groin area and large folds of the skin.
Application during pregnancy and lactation
During pregnancy (especially in the first trimester), topical application of the ointment in pregnant women is allowed only in cases where the intended benefit to the mother outweighs the potential risk to the fetus.
In such cases, the use of the drug should be short-lived and limited to small areas of the skin.
It is not known whether the components of the drug are excreted in breast milk.
Therefore, when prescribing Akriderm GK ointment during lactation, it is recommended to stop breastfeeding.
Contraindications
Hypersensitivity to any of the components of the drug, tuberculosis of the skin, skin manifestations of syphilis, chickenpox, herpes simplex, post-vaccination skin reactions, open wounds, children (up to 2 years).
Side effects
Itching, burning, irritation, dry skin, folliculitis, hypertrichosis, steroid acne, hypo-pigmentation, allergic reactions.
When using occlusive dressings - maceration, infection, skin atrophy, striae, prickly heat.
With prolonged treatment or application to a large surface - the development of systemic side effects: increased body weight, osteoporosis, increased blood pressure, edema, ulceration of the mucous membrane of the gastrointestinal tract, exacerbation of hidden foci of infection, hyperglycemia, agitation, insomnia , dysmenorrhea.
Interaction
The interaction of Akriderma GK with other drugs has not been established.
How to take, course of administration and dosage
Outwardly.
Cream Akriderm GK is applied to the affected skin, rubbing slightly, a small amount 2 times a day.
The duration of treatment is determined individually and depends on the nosological form and severity of the disease.
With dermatomycosis of the feet, the average duration of treatment
Name ENG
AKRIDERM GK
Clinical and pharmacological group
GCS for local use + antibiotic aminoglycoside + antifungal agent
ATX code
Betamethasone in combination with other drugs
Dosage
0.05% + 0.1% + 1% x 15g
Structure
Active ingredients: betamethasone dipropionate in terms of 100% substance - 0.064 g, clotrimazole in terms of 100% substance - 1 g, gentamicin sulfate in terms of gentamicin - 0.1 g
Excipients: propyl parahydroxybenzoate (nipazole), liquid paraffin (liquid paraffin), isopropyl myristate, petroleum jelly.
Indications
Simple and allergic dermatitis (especially complicated by secondary infection), diffuse neurodermatitis (including atopic dermatitis), limited neurodermatitis (including simple chronic lichen), eczema, dermatomycosis (dermatophytosis, candidiasis, versicolor versicolor), especially when localization in the groin and large folds of the skin.
Storage conditions and periods
At a temperature of 15-25 degrees.
Expiration date: 2 years
Contraindications
Hypersensitivity to any of the components of the drug, tuberculosis of the skin, skin manifestations of syphilis, chickenpox, herpes simplex, post-vaccination skin reactions, open wounds, children (up to 2 years).
INN / Active ingredient
betamethasone
Specifications
Category
Psoriasis
Scope of the drug
Dermatology
Release form
Ointment
Manufacturer country
Russia
Package quantity, pcs
one
Scope of application
Dermatology
,
Allergology
Minimum age from
2 years old
Way of introduction
Locally
,
Outwardly
Vacation conditions
Without recipe
Brand name
Akrikhin
The amount of the dosage form in the primary package
15 g
Primary packaging type
Tuba
Type of consumer packaging
Pack of cardboard
Anatomical and therapeutic characteristics
D07XC01 Betamethasone, in combination with other drugs
Dosage form
Ointment for external use
The target audience
Children
Dosage (volume) of the substance in the preparation
100 g: betamethasone dipropionate 0.064 g
Expiration date in days
730
Package weight, g
twenty
Mode of application
:
Outwardly.
Cream Akriderm GK is applied to the affected skin, rubbing slightly, a small amount 2 times a day.
The duration of treatment is determined individually and depends on the nosological form and severity of the disease.
With dermatomycosis of the feet, the average duration of treatment is 2-4 weeks.
Pharmaco-therapeutic group
:
Topical glucocorticosteroid + aminoglycoside antibiotic + antifungal agent
Information on technical characteristics, delivery set, country of manufacture "